AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1215859 — intervention group
Group type: EXPERIMENTAL
Intervention: tetracycline HCl 1 g
Number of subjects: 41
Study 1215859 — intervention group
Group type: EXPERIMENTAL
Intervention: tetracycline HCl + terpenes 100 mg
Number of subjects: 41
Study 1215859 — intervention group
Group type: EXPERIMENTAL
Intervention: minocycline 200 mg
Number of subjects: 41
Study 1215859 — intervention group
Group type: COMPARATOR
Intervention: cotrimoxazole (sulfamethoxazole 1.6 g + trimethoprim 320 mg)
Number of subjects: 41
Study 31868987 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 44
Study 31868987 — intervention group
Group type: COMPARATOR
Intervention: Sham-acupuncture
Number of subjects: 44
Study 31763286 — intervention group
Group type: COMPARATOR
Intervention: Manual extraction of maggots after instillation of chloroform and turpentine oil mixture
Number of subjects: 80
Study 31763286 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Ivermectin (6 mg each, two doses 24 hours apart)
Number of subjects: 80
Study 31763286 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic clearance of maggots at 24 hours
Number of subjects: 80
Study 31763286 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic clearance of maggots at 48 hours
Number of subjects: 80
Study 29333775 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1.0 μg·kg⁻¹ bolus, saline diluted to 10 mL, followed by maintenance dose of 0.1-0.4 mL·(kg·h)⁻¹ until 45 min before the end of operation)
Number of subjects: 80
Study 29333775 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (10 mL bolus, followed by maintenance dose of 0.1-0.4 mL·(kg·h)⁻¹ until 45 min before the end of operation)
Number of subjects: 80
Study 29333775 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 80
Study 29333775 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 80
Study 26070865 — intervention group
Group type: EXPERIMENTAL
Intervention: NaCl 0.9% (Group A)
Number of subjects: 233
Study 26070865 — intervention group
Group type: COMPARATOR
Intervention: NaCl 0.45% (Group B)
Number of subjects: 233
Study 24973546 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic-based intervention program (CBIP)
Number of subjects: 178
Study 24973546 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based intervention program (HBIP)
Number of subjects: 178
Study 24973546 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 178
Study 23052222 — intervention group
Group type: EXPERIMENTAL
Intervention: 600,000 IU vitamin D3
Number of subjects: 37
Study 23052222 — intervention group
Group type: EXPERIMENTAL
Intervention: 300,000 IU vitamin D3
Number of subjects: 37
Study 23052222 — intervention group
Group type: EXPERIMENTAL
Intervention: 100,000 IU vitamin D3
Number of subjects: 37
Study 23052222 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vitamin D3)
Number of subjects: 37
Study 19573672 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin adhesive (2-octylcyanoacrylate)
Number of subjects: 134
Study 19573672 — intervention group
Group type: COMPARATOR
Intervention: Subcuticular suture
Number of subjects: 134
Study 17312205 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular electroacupuncture (AE) with electrical stimulation, n = 76
Number of subjects: 149
Study 17312205 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupuncture (AA) without electrical stimulation, n = 37
Number of subjects: 149
Study 17312205 — intervention group
Group type: COMPARATOR
Intervention: Sham auricular electroacupuncture (NN) with no electrical stimulation, n = 36
Number of subjects: 149
Study 15498605 — intervention group
Group type: EXPERIMENTAL
Intervention: MSL-109 15 mg
Number of subjects: 82
Study 15498605 — intervention group
Group type: EXPERIMENTAL
Intervention: MSL-109 60 mg
Number of subjects: 82
Study 15498605 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 11430552 — intervention group
Group type: EXPERIMENTAL
Intervention: Indocyanine green (ICG) 0.25 mg/kg body weight (ICG1)
Number of subjects: 31
Study 11430552 — intervention group
Group type: EXPERIMENTAL
Intervention: Indocyanine green (ICG) 0.25 mg/kg body weight (ICG2)
Number of subjects: 31
Study 11430552 — intervention group
Group type: COMPARATOR
Intervention: Human albumin 20% 1.75 ml/kg body weight (Group ALB)
Number of subjects: 31
Study 11430552 — intervention group
Group type: COMPARATOR
Intervention: Hydroxyethyl starch 6% 5.25 ml/kg body weight (Group HAES)
Number of subjects: 31
Study 11430552 — intervention group
Group type: COMPARATOR
Intervention: Polygelatine 3.5% 7.0 ml/kg body weight (Group HAEM)
Number of subjects: 31
Study 9663222 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 interrupted 10-0 nylon sutures
Number of subjects: 62
Study 9663222 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 running 10-0 nylon sutures, each with 8 bites
Number of subjects: 62
Study 9663222 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 running 10-0 nylon sutures, each with 12 bites
Number of subjects: 62
Study 9663222 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 running 10-0 nylon sutures, each with 16 bites
Number of subjects: 62
Study 7818586 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg twice a day for 4 weeks
Number of subjects: 652
Study 7818586 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 652
Study 3337412 — intervention group
Group type: COMPARATOR
Intervention: Control (no activated charcoal)
Number of subjects: 13
Study 3337412 — intervention group
Group type: EXPERIMENTAL
Intervention: One-dose activated charcoal (50 g)
Number of subjects: 13
Study 3337412 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-dose activated charcoal (50 g)
Number of subjects: 13
Study 3337412 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dose activated charcoal (50 g)
Number of subjects: 13
Study 2048658 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl
Number of subjects: 20
Study 2048658 — intervention group
Group type: COMPARATOR
Intervention: Intravenous fentanyl
Number of subjects: 20
Study 788767 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomocycline (Megaclor) for 3 months
Number of subjects: 60
Study 788767 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 60
Study 788767 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 60
Study 788767 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomocycline over long periods
Number of subjects: 60
Study 31409363 — intervention group
Group type: EXPERIMENTAL
Intervention: Food bar (FB) containing 20g of whey protein, 25g of isomalto-oligosaccharides, and 7g of fat
Number of subjects: 12
Study 31409363 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate matched dextrose comparator (CHO)
Number of subjects: 12
Study 31409363 — intervention group
Group type: EXPERIMENTAL
Intervention: Food bar (FB)
Number of subjects: 12
Study 28512998 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based learning collaborative intervention for TTT adherence over 9 months
Number of subjects: 641
Study 28512998 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 641
Study 26429049 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy combined with transanal endoscopic microsurgery (LT group)
Number of subjects: 60
Study 26429049 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic surgery (LA group)
Number of subjects: 60
Study 23986778 — intervention group
Group type: EXPERIMENTAL
Intervention: High Protein (HP) diet
Number of subjects: 60
Study 23986778 — intervention group
Group type: COMPARATOR
Intervention: Energy-restricted control diet
Number of subjects: 60
Study 21173495 — intervention group
Group type: EXPERIMENTAL
Intervention: Waon therapy (daily for 4 weeks)
Number of subjects: 40
Study 21173495 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard optimal medications for CHF)
Number of subjects: 40
Study 19889188 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG lead aVR
Number of subjects: 136
Study 19889188 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in aVR
Number of subjects: 136
Study 17324689 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 0
Study 17324689 — intervention group
Group type: EXPERIMENTAL
Intervention: Atypical antipsychotics
Number of subjects: 0
Study 17324689 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpharmacological management
Number of subjects: 0
Study 15070944 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting pegylated recombinant leptin (PEG-OB)
Number of subjects: 0
Study 15070944 — intervention group
Group type: COMPARATOR
Intervention: Weight loss
Number of subjects: 0
Study 15070944 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss with PEG-OB treatment
Number of subjects: 0
Study 15070944 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG-OB treatment
Number of subjects: 0
Study 11240978 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil
Number of subjects: 52
Study 11240978 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine (Control)
Number of subjects: 52
Study 9492731 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole (500 mg intravenous infusion before operation and again 8 hours later)
Number of subjects: 258
Study 9492731 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 258
Study 9492731 — intervention group
Group type: EXPERIMENTAL
Intervention: Total population (metronidazole + placebo)
Number of subjects: 258
Study 7810383 — intervention group
Group type: EXPERIMENTAL
Intervention: Maloprim (dapsone/pyrimethamine)
Number of subjects: 392
Study 7810383 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 392
Study 3128132 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin infusion, 1 to 2 micrograms.kg‐1.min‐1
Number of subjects: 22
Study 3128132 — intervention group
Group type: COMPARATOR
Intervention: No nitroglycerin infusion
Number of subjects: 22
Study 27778088 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding
Number of subjects: 73
Study 27778088 — intervention group
Group type: COMPARATOR
Intervention: Formula feeding
Number of subjects: 73
Study 27130167 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital Episode Statistics (HES) data using NHS reference costs
Number of subjects: 292
Study 27130167 — intervention group
Group type: COMPARATOR
Intervention: Medical record data
Number of subjects: 292
Study 25919389 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal thoracic impedance (ITI) monitoring using RS‐207 monitor
Number of subjects: 100
Study 25919389 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pleural effusion)
Number of subjects: 100
Study 22488751 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy treatment with rectal balloon training and pelvic floor muscle training
Number of subjects: 80
Study 22488751 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer time since FI onset
Number of subjects: 80
Study 22488751 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of constipating medication
Number of subjects: 80
Study 22488751 — intervention group
Group type: EXPERIMENTAL
Intervention: Any obstetric factor
Number of subjects: 80
Study 22488751 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiencing minor embarrassment
Number of subjects: 80
Study 20048226 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-session group coping skills intervention targeting personality profiles
Number of subjects: 732
Study 20048226 — intervention group
Group type: COMPARATOR
Intervention: Control no-intervention condition
Number of subjects: 732
Study 18633251 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin AUC 6.0 day 1 and paclitaxel 70 mg/m2 day 1, 8, 15 every 4 weeks followed by gemcitabine 1.0 g/m2 day 1, 8, 15 every 4 weeks (Group CP)
Number of subjects: 51
Study 18633251 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin AUC 2.0 and gemcitabine 0.8 g/m2 day 1, 8 every 3 weeks followed by docetaxel 60 mg/m2 day 1, 8 every 3 weeks (Group CG)
Number of subjects: 51
Study 16224532 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Bass method
Number of subjects: 40
Study 16224532 — intervention group
Group type: COMPARATOR
Intervention: Vertical method
Number of subjects: 40
Study 12898873 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with vitiligo
Number of subjects: 38
Study 12898873 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy children with mild pityriasis capitis)
Number of subjects: 38
Study 10224335 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifametane (300 mg single oral dose)
Number of subjects: 8
Study 10224335 — intervention group
Group type: COMPARATOR
Intervention: Rifampicin (300 mg single oral dose)
Number of subjects: 8
Study 9023072 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency contract condition
Number of subjects: 39
Study 9023072 — intervention group
Group type: COMPARATOR
Intervention: No contingencies condition
Number of subjects: 39
Study 1801540 — intervention group
Group type: EXPERIMENTAL
Intervention: Selegiline (10 mg/day)
Number of subjects: 54
Study 1801540 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 6742536 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.1 mg/kg for <65 years; 0.085 mg/kg for ≥65 years)
Number of subjects: 0
Study 6742536 — intervention group
Group type: COMPARATOR
Intervention: Diazepam (0.2 mg/kg for <65 years; 0.15 mg/kg for ≥65 years)
Number of subjects: 0
Study 31812854 — intervention group
Group type: EXPERIMENTAL
Intervention: Child and parent satisfaction ratings (Arm 1)
Number of subjects: 600
Study 31812854 — intervention group
Group type: COMPARATOR
Intervention: Parent report only (Arm 2)
Number of subjects: 600
Study 29304140 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Exercise (AE)
Number of subjects: 106
Study 29304140 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Lymphatic Drainage (MLD)
Number of subjects: 106
Study 26083427 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (2%) via intravenous bolus (1.5 mg/kg) followed by infusion at 2 mg/kg/h until the end of surgery
Number of subjects: 94
Study 26083427 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (same volume as lidocaine)
Number of subjects: 94
Study 26083427 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (2%)
Number of subjects: 94
Study 24291444 — intervention group
Group type: EXPERIMENTAL
Intervention: Singing intervention
Number of subjects: 24
Study 24291444 — intervention group
Group type: COMPARATOR
Intervention: Active music therapy control
Number of subjects: 24
Study 22552687 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet only (DO; n = 14, ≈ 6000 kJ/day)
Number of subjects: 50
Study 22552687 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and aerobic exercise (DA; n = 16, ≈ 6000 kJ/day and five walking sessions/week)
Number of subjects: 50
Study 22552687 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and combined aerobic-resistance exercise (DC; n = 20, ≈ 6000 kJ/day, three walking and two strength sessions/week)
Number of subjects: 50
Study 20196183 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 23
Study 20196183 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 17666280 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative non-heparin anticoagulants (danaparoid, lepirudin, argatroban)
Number of subjects: 0
Study 16135578 — intervention group
Group type: EXPERIMENTAL
Intervention: Drospirenone 3 mg and Ethinyl Estradiol 20 microg (24/4 regimen)
Number of subjects: 450
Study 16135578 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 450
Study 11906496 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinafloxacin monotherapy (200 mg every 12 h)
Number of subjects: 419
Study 11906496 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime (2 g every 8 h) plus Amikacin (15 mg/kg per day)
Number of subjects: 419
Study 9949709 — intervention group
Group type: EXPERIMENTAL
Intervention: Mood music during word generation and recall (pleasantness dimension)
Number of subjects: 0
Study 9949709 — intervention group
Group type: EXPERIMENTAL
Intervention: Mood music during word generation and recall (arousal dimension)
Number of subjects: 0
Study 9949709 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous changes in both dimensions of mood (pleasantness and arousal)
Number of subjects: 0
Study 7751885 — intervention group
Group type: EXPERIMENTAL
Intervention: TURB plus BCG
Number of subjects: 86
Study 7751885 — intervention group
Group type: COMPARATOR
Intervention: TURB
Number of subjects: 86
Study 2405347 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro antibody production of HIV‐specific IgG
Number of subjects: 0
Study 6449891 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic regular GnRH
Number of subjects: 10
Study 6449891 — intervention group
Group type: EXPERIMENTAL
Intervention: Analogue (D-TRp6) GnRH
Number of subjects: 10
Study 6449891 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31379236 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative amiodarone
Number of subjects: 12758
Study 29219599 — intervention group
Group type: EXPERIMENTAL
Intervention: Extrapolation to the zero noise limit
Number of subjects: 0
Study 29219599 — intervention group
Group type: EXPERIMENTAL
Intervention: Resampling randomized circuits according to a quasiprobability distribution
Number of subjects: 0
Study 25872505 — intervention group
Group type: EXPERIMENTAL
Intervention: Online self-help program (deprexis®) with 12 weekly tasks during inpatient treatment
Number of subjects: 240
Study 25872505 — intervention group
Group type: COMPARATOR
Intervention: Access to an online platform with weekly updated information on depression
Number of subjects: 240
Study 23798331 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold knife (n = 8)
Number of subjects: 15
Study 23798331 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrocautery (n = 7)
Number of subjects: 15
Study 21173780 — intervention group
Group type: COMPARATOR
Intervention: Non-invasive cardiac output measurements using Innocor at rest
Number of subjects: 9
Study 21173780 — intervention group
Group type: COMPARATOR
Intervention: Non-invasive cardiac output measurements using Innocor during arm-crank exercise
Number of subjects: 9
Study 21173780 — intervention group
Group type: COMPARATOR
Intervention: Non-invasive cardiac output measurements using Innocor during wheelchair exercise
Number of subjects: 9
Study 19728564 — intervention group
Group type: EXPERIMENTAL
Intervention: Compounds 1-7
Number of subjects: 2
Study 19728564 — intervention group
Group type: EXPERIMENTAL
Intervention: Compounds 1, 3, 4, 5, 6, and 7
Number of subjects: 2
Study 19728564 — intervention group
Group type: COMPARATOR
Intervention: Compound 5
Number of subjects: 2
Study 19728564 — intervention group
Group type: EXPERIMENTAL
Intervention: Jurkat cells
Number of subjects: 2
Study 17761550 — intervention group
Group type: EXPERIMENTAL
Intervention: Natalizumab
Number of subjects: 625
Study 15611489 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation plus exercise
Number of subjects: 131
Study 15611489 — intervention group
Group type: COMPARATOR
Intervention: Exercise alone
Number of subjects: 131
Study 15611489 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation
Number of subjects: 131
Study 11763110 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (50 mg)
Number of subjects: 6
Study 11763110 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (100 mg)
Number of subjects: 6
Study 11763110 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (10 mg)
Number of subjects: 6
Study 11763110 — intervention group
Group type: EXPERIMENTAL
Intervention: Promethazine (10 mg)
Number of subjects: 6
Study 9722810 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based outreach HIV intervention
Number of subjects: 250
Study 9722810 — intervention group
Group type: COMPARATOR
Intervention: Control group (no outreach services)
Number of subjects: 250
Study 9032106 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine (20-40 mg once daily)
Number of subjects: 49
Study 9032106 — intervention group
Group type: COMPARATOR
Intervention: Lisinopril (10-20 mg once daily)
Number of subjects: 49
Study 1742648 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sodium cromoglycate
Number of subjects: 20
Study 1742648 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 7099364 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline 50 mg
Number of subjects: 15
Study 7099364 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 31852892 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic correlation with body fat % and fat-free mass in anorexia nervosa, schizophrenia, and obsessive-compulsive disorder.
Number of subjects: 217568
Study 31852892 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic correlation with body fat % and fat-free mass in ADHD, alcohol dependence, insomnia, and heavy smoking.
Number of subjects: 217568
Study 31852892 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization for schizophrenia, anorexia nervosa, and higher education.
Number of subjects: 217568
Study 31852892 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher body fat % as a risk factor for ADHD and heavy smoking.
Number of subjects: 217568
Study 31852892 — intervention group
Group type: EXPERIMENTAL
Intervention: Education years and ADHD genetic overlap with childhood obesity.
Number of subjects: 217568
Study 28836546 — intervention group
Group type: EXPERIMENTAL
Intervention: Space Glucose Control (SGC) system
Number of subjects: 70
Study 28836546 — intervention group
Group type: COMPARATOR
Intervention: Routine glucose management
Number of subjects: 70
Study 25667240 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline PSQ score increase (1-SD)
Number of subjects: 185
Study 25667240 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher baseline PSQ scores (greater symptom burden)
Number of subjects: 185
Study 25667240 — intervention group
Group type: COMPARATOR
Intervention: Polysomnographic data
Number of subjects: 185
Study 25667240 — intervention group
Group type: COMPARATOR
Intervention: PSQ and polysomnographic data
Number of subjects: 185
Study 25087079 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance-trained athletes (ETs)
Number of subjects: 60